Advertisement
Screener

CRYO-CELL INTERNATIONAL, INC. (CCEL) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

1.7 / 5 stars · 40/120 Roast Me

CRYO-CELL INTERNATIONAL, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $278.21 thousand for the 12-month period ending 2025-11-30, per its 10-K filed 2026-02-27.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-27

  • CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $278.21K, a 98.87% increase from fiscal 2024.
  • CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $139.89K, a 48.64% increase from fiscal 2023.
  • CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $94.11K, a 514.61% increase from fiscal 2022.
  • CRYO-CELL INTERNATIONAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $15.31K, a 92.78% decline from fiscal 2021.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month
2025-11-30$278.21K
10-K · filed 2026-02-27
2024-11-30$139.89K
10-K · filed 2026-02-27
2023-11-30$94.11K
10-K · filed 2025-02-28
2022-11-30$15.31K
10-K · filed 2024-02-28
2021-11-30$212.22K
10-K · filed 2023-02-28
2020-11-30$6.87K
10-K · filed 2022-02-22
2019-11-30$26.33K
10-K · filed 2021-03-01
2018-11-30$260.85K
10-K · filed 2020-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
Park Dental Partners, Inc. (PARK)United States$0.094B
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
agilon health, inc. (AGL)United States$1.272B-7.76
Progyny, Inc. (PGNY)United States$1.994B28.37
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80